HAI Book 2025 - Flipbook - Page 40
Board
#
Presenter
Day
Poster Title
Silva-Rodríguez,
Jesús
Thursday
89
Silva-Rodríguez,
Jesús
Friday
129
Singh-Reilly, Neha
Thursday
95
Singh-Reilly, Neha
Friday
145
Slade, Elliott
Friday
160
Smith, Anna
Friday
135
Soares, Carolina
Friday
150
SoleimaniMeigooni, David
Friday
118
Tennant, Victoria
Friday
143
Thibault, Emma
Friday
164
Thompson,
Jackson
Friday
156
Tiss, Amal
Friday
157
Tissot, Cécile
Friday
142
Tonietto, Matteo
Friday
122
Townsend, Diana
Friday
147
Trudel, Lydia
Friday
165
Unschuld, Paul
Wednesday
16
Van Egroo, Maxime
Friday
138
Villemagne, Victor
Wednesday
04
Astrogliosis, a potential non-A´ pathway to tau
Villemagne, Victor
Friday
153
Astrogliosis in the early-stages of Alzheimer's disease
Heterogeneity of FDG-PET patterns among tau-negative
amnestic patients
Long-term cognitive and biomarker trajectories of
cognitively unimpaired individuals with elevated plasma
ptau-217
Relationship between neuroinflammatory ER176-PET and
functional connectivity in Progressive Apraxia of Speech
Relationship between flortaucipir-PET and quantitative
susceptibility mapping in atypical Alzheimer9s disease
Impact of early-stage amyloidosis on tau accumulation
throughout the medial temporal lobe and neocortex
Multi-morbidity and Alzheimer9s disease pathology across
the lifespan in adults with Down syndrome
Characterization of PART using MK-6240, Flortaucipir, and
plasma p-tau217
Calibration of multi-site raters for prospective visual read of
amyloid PET scans acquired across the ADRC Consortium
for Clarity in ADRD Research Through Imaging (CLARiTI)
Relationship between metabolic syndrome biomarkers and
regional tau accumulation in cognitively unimpaired older
adults
Neocortical amyloid spatial extent predicts cognitive
decline over time in memory and executive function
domains
Amyloid spatial extent captures early tau burden and
cognitive deficits, measured by PACC and digital clock
drawing test, in preclinical Alzheimer9s disease
Findings from dynamic [18F]-MK6240 PET imaging after
motion and partial volume corrections
Best practices for tau-PET tracer harmonization in
Alzheimer's research
Impact of amyloid removal on cerebral volume changes with
Gantenerumab
Patterns of cognitive decline in individuals with elevated ptau217 and low levels (
